| Financial Year |
March 31 2023 |
| Monetary Funds |
795,695,680.52 |
| Held-for-trading Financial Assets |
308,267.10 |
| Notes Receivable |
10,750,005.40 |
| Accounts Receivable |
266,224,646.35 |
| Advances to Suppliers |
40,470,924.70 |
| Other Receivables |
128,344,582.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,703,385,197.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
158,422,814.33 |
| Total Current Assets |
5,103,602,118.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
291,300,105.54 |
| Investment Properties |
1,097,795,900.00 |
| Fixed Assetes |
7,381,707,026.47 |
| Under-construction Projects |
2,483,557,510.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
242,884,088.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,923,874.14 |
| Deferred Income Tax Assets |
495,021,723.92 |
| Other Non-Current Assets |
4,312,353,210.62 |
| Sub-Total of Non-Current Assets |
16,702,403,970.10 |
| Total Assets |
21,806,006,088.45 |
| Short-Term Loans |
540,624,761.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
447,141,098.14 |
| Accounts Payable |
2,361,733,849.71 |
| Accounts Received In Advance |
23,393,533.56 |
| Employee Compensation Payable |
18,427,478.72 |
| Taxes Payable |
1,219,988,754.12 |
| Interest Payable |
-- |
| Dividend Payable |
22,120,000.00 |
| Other payables |
434,054,412.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
742,053,062.01 |
| Other Current Liabilities |
52,610,173.38 |
| Sub-Total of Current Liabilities |
6,649,837,091.45 |
| Long-term Loans |
3,931,160,370.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,227,615,982.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,052,733,050.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,561,419,641.80 |
| Total Liabilities |
15,211,256,733.25 |
| Paid-In Capital(Or Share Stock) |
1,696,001,434.00 |
| Capital Surplus |
32,455,419.80 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
321,626,673.09 |
| Undistributed Profits |
4,427,999,248.32 |
| Minority Stockholder's Interest |
738,764,398.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,855,984,956.66 |
| Owner's Equity（Stockholder's Equity） |
6,594,749,355.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,806,006,088.45 |
